TY - JOUR
T1 - Cervical cancer screening
AU - Partridge, Edward E.
AU - Abu-Rustum, Nadeem
AU - Campos, Susan
AU - Fahey, Patrick J.
AU - Greer, Benjamin E.
AU - Lele, Subodh M.
AU - Lieberman, Richard W.
AU - Lipscomb, Gary H.
AU - Morgan, Mark
AU - Nava, Maria Enriqueta R.
AU - Reynolds, R. Kevin
AU - Singh, Diljeet K.
AU - Smith-McCune, Karen
AU - Teng, Nelson
AU - Trimble, Cornelia Liu
AU - Valea, Fidel
AU - Wilczynski, Sharon
PY - 2008/1
Y1 - 2008/1
N2 - Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.
AB - Cervical carcinoma remains a health issue for women worldwide. Cervical cytology screening is the current method for early detection, and the NCCN Cervical Cancer Screening Clinical Practice Guidelines in Oncology provide direction for evaluating and managing this process, including clarified and revised recommendations on screening techniques and intervals and follow-up of abnormal screening results, including colposcopy. Human papillomavirus (HPV) DNA testing for primary cervical cancer has been approved by the FDA, and HPV DNA testing for high-risk virus types can also be used as a component of both primary screening and workup of abnormal cytology results. Colposcopy, along with colposcopically directed biopsies, has become the primary method for evaluating women with abnormal cervical cytologies. Special considerations for colposcopy performed during pregnancy are also discussed.
KW - Biopsy
KW - Cancer screening
KW - Cervical cancer
KW - Cold-knife conization
KW - Colposcopy
KW - Human papillomavirus testing
KW - Intraepithelial neoplasia
KW - Liquid-based cytology
KW - Loop electrosurgical excision procedure
KW - NCCN clinical practice guidelines
KW - Pap test
KW - Papanicolaou test
UR - http://www.scopus.com/inward/record.url?scp=38949103654&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38949103654&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2008.0007
DO - 10.6004/jnccn.2008.0007
M3 - Review article
C2 - 18267060
AN - SCOPUS:38949103654
SN - 1540-1405
VL - 6
SP - 58
EP - 82
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 1
ER -